Company news
OptimizeRx Corporation news in 2024
OptimizeRx Corporation's news releases, calls and decks from 2024, newest first.
OptimizeRx Announces Departure of CEO William Febbo and Appointment of Stephen Silvestro as Interim CEO
December 22, 2024
OptimizeRx Reports Third Quarter 2024 Financial Results
November 12, 2024
OptimizeRx Sets Third Quarter 2024 Conference Call for November 13, 2024 at 4: 30 p.m. ET
October 30, 2024
OptimizeRx Continues to Expand its Strategic Relationship with a Top-Tier Pharma Client via a Multi-Brand, Multi-Solution Investment Commitment with Over $10M In-Year Total Value
September 9, 2024
OptimizeRx Launches Novel Brand Eligibility Technology, Enabling Dynamic Direct to Consumer Marketing for Healthcare Audiences
September 8, 2024
OptimizeRx Reports Second Quarter 2024 Financial Results
August 7, 2024
OptimizeRx Sets Second Quarter 2024 Conference Call for August 8, 2024 at 4: 30 p.m. ET
July 24, 2024
OptimizeRx Delivers AI-Guided Privacy-Compliant Platform for Pharmaceutical Brand Marketing Amid Evolving Consumer Privacy Legislation
July 22, 2024
OptimizeRx Demonstrates Measurable Script Lift for a Major Depressive Disorder Brand Targeting Physicians of Hard-to-Reach Patients
July 14, 2024
New White Paper Highlights How Closing the Health Information Gap Between Doctors and Patients Improves Life Science Marketing & Adds Value to Clinical Conversations
June 19, 2024
OptimizeRx Reports First Quarter 2024 Financial Results
May 13, 2024
OptimizeRx to Participate in Upcoming Investor Conferences
May 5, 2024
OptimizeRx Provides Business Update and Sets First Quarter 2024 Conference Call for May 14, 2024 at 4: 30 p.m. ET
April 25, 2024
OptimizeRx Releases 2024 Environmental, Social, and Governance (ESG) Report
April 17, 2024
OptimizeRx Reports Strong Fourth Quarter and Full Year 2023 Financial Results
April 15, 2024
OptimizeRx Named America’s Fastest-Growing Company for Fifth Year in a Row
April 10, 2024
OptimizeRx Sets Fourth Quarter 2023 Conference Call for March 28, 2024 at 8: 30 a.m. ET
March 24, 2024
OptimizeRx Provides an Update on the Timing of Earnings Call and Reaffirms Prior Revenue and Adjusted EBITDA Estimates for FY2023
March 10, 2024
OptimizeRx Powers Walmart's ‘Specialty Pharmacies of the Community’ Outreach Effort
March 3, 2024
OptimizeRx Announces Strategic Board Changes to Support Growth and Evolving Landscape
January 24, 2024
OptimizeRx Preannounces Select Expected 2023 Financials and Provides a Business Update
January 8, 2024